Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis

Journal of Nuclear Cardiology

Volumn 21, Issue 5, 2014, Pages 940-943

  Waller, Alfonso H ^a   Blankstein, Ron ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; FEMALE; HEART DISEASES; HUMAN; MALE; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SARCOIDOSIS;

FEMALE; FLUORODEOXYGLUCOSE F18; HEART DISEASES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929942231     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-014-9921-5     Document Type: Editorial

References (9)

1. Iannuzzi MC, Fontana JR. Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011;305:391-9.
2. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
3. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329-36.
4. 18F-flurodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014;21:166-74.
5. 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008;35:933-41.
6. Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging 2010;3:1219–28.
7. 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98.
8. Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014. doi:10.1007/s12350-014-9901-9
9. 18F-flurodoexyglucose positron emission tomography? Circ Cardiovasc Imaging 2013;6:617-26.